![Frank Verwiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 742 613 $ al 30/06/2026
Frank A. G. M. Verwiel es un empresario holandés que ha estado al frente de 6 empresas diferentes. Es presidente de ObsEva SA, presidente de Intellia Therapeutics, Inc. y presidente de Aptalis Pharma US, Inc. También forma parte del consejo de administración de Bavarian Nordic An y Bavarian Nordic GmbH. En su trayectoria profesional anterior, Frank A. G. M. Verwiel ocupó los cargos de vicepresidente de Hipertensión y Marketing Mundial de Salud Humana en Merck & Co., Inc., presidente, director general y consejero de Aptalis Pharma, Inc., presidente y director general de Aptalis Pharma SAS, presidente, director general y consejero de Aptalis Holdings, Inc. y director y consejero de la sección de salud de la Organización de Innovación Biotecnológica. Frank A. G. M. Verwiel obtuvo un MBA en INSEAD y un doctorado en la Universidad Erasmus de Rotterdam.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/06/2026 | 35.148 ( 0,03 % ) | 594 704 $ | 30/06/2026 | |
BAVARIAN NORDIC A/S 0,01 % | 31/12/2025 | 5.293 ( 0,01 % ) | 147 909 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BAVARIAN NORDIC A/S | Director/Miembro de la Junta | 20/04/2016 |
| INTELLIA THERAPEUTICS, INC. | Presidente | 01/02/2020 |
Aptalis Pharma US, Inc.
 Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Presidente | - |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Director/Miembro de la Junta | 01/01/2016 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Director/Miembro de la Junta | 01/08/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| OBSEVA SA | Presidente | 18/05/2022 |
| ACHILLION PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 28/01/2020 |
| AVEXIS INC | Director/Miembro de la Junta | 01/06/2018 |
| INTERMUNE INC | Director/Miembro de la Junta | 01/09/2014 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Health Technology |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TA SASU
 TA SASU Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on gastrointestinal diseases and cystic fibrosis | Health Technology |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Health Technology |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operating as a holding company that develops, manufactures, licenses, markets and distributes therapies | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
